Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01577329 · ClinicalTrials.gov registry record · NA

Mindfulness Mediation Intervention in Chronic Obstructive Pulmonary Disease (COPD)

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
41
Enrollment target

NCT01577329: Completed NA study, sponsored by University of Michigan.

NCT01577329 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01577329, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
41 participants
Enrollment target

Study Summary

The purpose of this study is to assess the feasibility and potential impact of an eight week program of meditation on expiratory time, anxiety and dyspnea in people with COPD.

Primary Outcome

Breathing patterns will be measured at baseline using inductive plethysmography at baseline and at week eight. During that eight week time period the treatment group will have been exposed to a once a week mindfulness meditation class and the control group will have been exposed to health care as usual.

Interventions

  • BEHAVIORAL Mindfulness meditation

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2011-10
Est. Completion 2015-07
Phase NA
University of Michigan

1,327 total trials

What the finished NCT01577329 record still lists

NCT01577329 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Mindfulness meditation is the first listed.

NCT01577329 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01577329 about?

NCT01577329 is a clinical study titled "Mindfulness Mediation Intervention in Chronic Obstructive Pulmonary Disease (COPD)". The purpose of this study is to assess the feasibility and potential impact of an eight week program of meditation on expiratory time, anxiety and dyspnea in people with COPD.

What is the current status of trial NCT01577329?

This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2011-10. Estimated completion is 2015-07.

What interventions are being tested in trial NCT01577329?

The interventions under investigation include: Mindfulness meditation (BEHAVIORAL).

Who is sponsoring clinical trial NCT01577329?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01577329's enrollment target sits among peer trials

41 1446th of 2000 higher than 554 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03449238 · 41 participants · Phase 1

    Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

  • NCT03900793 · 41 participants · Phase 1

    Losartan + Sunitinib in Treatment of Osteosarcoma

  • NCT04082520 · 41 participants · Phase 2

    Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

  • NCT04220190 · 41 participants · Phase 2

    RAPA-501 Therapy for ALS

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01577329, the US trial registry maintained by the National Library of Medicine. NCT01577329 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.